Virtual Reality Market 2023-2027 | The use of virtual reality in training and simulation for aerospace and defense is the market trend- Technavio
NEW YORK, Nov. 4, 2023 /PRNewswire/ — The virtual reality market is categorized by Technavio as a subsegment of the application software market. According to projections, the market will grow by USD 1,81,340.96 million. An important trend in the market for virtual reality is the use of virtual
Zeta Phi Beta Sorority, Incorporated Announces Olympic Gold Medalist, Professional Athlete, and Entrepreneur, Angel McCoughtry, as an Honorary Member
WASHINGTON, Nov. 4, 2023 /PRNewswire/ — Zeta Phi Beta Sorority, Incorporated, one of the country’s largest women’s service organizations, is delighted to announce the induction of Angel McCoughtry as Honorary Members into its Alpha Omega Chapter. This accomplished woman has demonst
Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy
SHANGHAI, Nov. 4, 2023 /PRNewswire/ — On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX10
Attorneys Alert Marshall Fire Victims To Pending Claim Deadline
BOULDER, Colo., Nov. 4, 2023 /PRNewswire/ — Singleton Schreiber, America’s premier fire litigation firm, is alerting those impacted by the Marshall Fire that the deadline to file a suit against the utility responsible for starting the fires is just over two months away. In July of this y
Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study
Boehringer Ingelheim and Carelon Research have conducted the first large-scale U.S. validation of a new AI-driven tool for chronic kidney disease (CKD) The Klinrisk model predicted disease progression in over 80% of individuals at all stages of the disease, based on data from a diverse population of
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation – WALD, WALDW
NEW YORK, Nov. 4, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast PLC (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading
IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years
Phase 3 results presented at the AAO Annual Meeting demonstrated the IZERVAY treatment effect more than doubled over 2 years compared to 1 year IZERVAY safety profile was consistent with year 1, with no cases of ischemic optic neuropathy or retinal vasculitis Over 2 years, only a slight increased in
Promontory Therapeutics Presents Data on Molecular Mechanisms of PT-112’s Immunogenic Effects
PT-112’s mechanism of action inhibits ribosomal biogenesis, promoting immunogenic cancer cell death through cancer cell organelle stresses Data presented at the Society for Immunotherapy of Cancer’s 38th Annual Meeting NEW YORK, Nov. 4, 2023 /PRNewswire/ — Promontory Therapeutics
ROSEN, A TOP RANKED LAW FIRM, Encourages Global Cord Blood Corporation Investors to Inquire About Securities Class Action Investigation – CORBF
NEW YORK, Nov. 4, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Global Cord Blood Corporation (OTC: CORBF) resulting from allegations that Global Cord may have issued materiall
Upholding legacy of Flying Tigers, renewing China-U.S. people-to-people friendship
BEIJING, Nov. 4, 2023 /PRNewswire/ — An event to commemorate the 80th anniversary of the U.S. 14th Air Force’s participation in Chinese People’s War of Resistance against Japanese Aggression was held at the Museum of the War of Chinese People’s Resistance against Japanese Agg